142 related articles for article (PubMed ID: 38659322)
1. Blood serum levels of PACAP and migraine onset: A systematic review and meta-analysis of observational studies.
Zhu G; Wang M; Kong F
Headache; 2024 May; 64(5):573-588. PubMed ID: 38659322
[TBL] [Abstract][Full Text] [Related]
2. Interictal plasma pituitary adenylate cyclase-activating polypeptide levels are decreased in migraineurs but remain unchanged in patients with tension-type headache.
Han X; Dong Z; Hou L; Wan D; Chen M; Tang W; Yu S
Clin Chim Acta; 2015 Oct; 450():151-4. PubMed ID: 26296898
[TBL] [Abstract][Full Text] [Related]
3. Serum CGRP, VIP, and PACAP usefulness in migraine: a case-control study in chronic migraine patients in real clinical practice.
Pérez-Pereda S; Toriello-Suárez M; Ocejo-Vinyals G; Guiral-Foz S; Castillo-Obeso J; Montes-Gómez S; Martínez-Nieto RM; Iglesias F; González-Quintanilla V; Oterino A
Mol Biol Rep; 2020 Sep; 47(9):7125-7138. PubMed ID: 32951099
[TBL] [Abstract][Full Text] [Related]
4. No Change in Interictal PACAP Levels in Peripheral Blood in Women With Chronic Migraine.
Cernuda-Morollón E; Riesco N; Martínez-Camblor P; Serrano-Pertierra E; García-Cabo C; Pascual J
Headache; 2016 Oct; 56(9):1448-1454. PubMed ID: 27634731
[TBL] [Abstract][Full Text] [Related]
5. Alterations in PACAP-38-like immunoreactivity in the plasma during ictal and interictal periods of migraine patients.
Tuka B; Helyes Z; Markovics A; Bagoly T; Szolcsányi J; Szabó N; Tóth E; Kincses ZT; Vécsei L; Tajti J
Cephalalgia; 2013 Oct; 33(13):1085-95. PubMed ID: 23598374
[TBL] [Abstract][Full Text] [Related]
6. CGRP and PACAP-38 play an important role in diagnosing pediatric migraine.
Liu J; Wang G; Dan Y; Liu X
J Headache Pain; 2022 Jun; 23(1):68. PubMed ID: 35698032
[TBL] [Abstract][Full Text] [Related]
7. Targeting pituitary adenylate cyclase-activating polypeptide (PACAP) with monoclonal antibodies in migraine prevention: a brief review.
Rustichelli C; Lo Castro F; Baraldi C; Ferrari A
Expert Opin Investig Drugs; 2020 Nov; 29(11):1269-1275. PubMed ID: 32877252
[TBL] [Abstract][Full Text] [Related]
8. PACAP-38 and sex hormones in women with migraine: exploratory analysis of a cross-sectional, matched cohort study.
Storch E; Overeem LH; Terhart M; Fitzek MP; Lange KS; Reuter U; Raffaelli B
J Headache Pain; 2024 Jun; 25(1):98. PubMed ID: 38858641
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Temporal alterations of pituitary adenylate cyclase activating polypeptide and its receptors in a rat model induced by recurrent chemical stimulations: Relevant to chronic migraine.
Wu H; Dong Z; Liu Y; Zhang Q; Zhang M; Hu G; Yu S; Han X
Mol Pain; 2023; 19():17448069231152129. PubMed ID: 36604785
[No Abstract] [Full Text] [Related]
11. Transport of the pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier: implications for migraine.
Amin FM; Schytz HW
J Headache Pain; 2018 May; 19(1):35. PubMed ID: 29785578
[TBL] [Abstract][Full Text] [Related]
12. Serotonin and Neuropeptides in Blood From Episodic and Chronic Migraine and Cluster Headache Patients in Case-Control and Case-Crossover Settings: A Systematic Review and Meta-Analysis.
Frederiksen SD; Bekker-Nielsen Dunbar M; Snoer AH; Deen M; Edvinsson L
Headache; 2020 Jun; 60(6):1132-1164. PubMed ID: 32293721
[TBL] [Abstract][Full Text] [Related]
13. Targeting the PACAP-38 pathway is an emerging therapeutic strategy for migraine prevention.
Pellesi L; Ashina M; Martelletti P
Expert Opin Emerg Drugs; 2024 Mar; 29(1):57-64. PubMed ID: 38337150
[TBL] [Abstract][Full Text] [Related]
14. The change of plasma pituitary adenylate cyclase-activating polypeptide levels after aneurysmal subarachnoid hemorrhage.
Jiang L; Wang WH; Dong XQ; Yu WH; Du Q; Yang DB; Wang H; Shen YF
Acta Neurol Scand; 2016 Aug; 134(2):131-9. PubMed ID: 26471292
[TBL] [Abstract][Full Text] [Related]
15. Pituitary adenylate cyclase-activating polypeptide receptors in the trigeminovascular system: implications for migraine.
Sundrum T; Walker CS
Br J Pharmacol; 2018 Nov; 175(21):4109-4120. PubMed ID: 28977676
[TBL] [Abstract][Full Text] [Related]
16. From CGRP to PACAP, VIP, and Beyond: Unraveling the Next Chapters in Migraine Treatment.
Tanaka M; Szabó Á; Körtési T; Szok D; Tajti J; Vécsei L
Cells; 2023 Nov; 12(22):. PubMed ID: 37998384
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of PACAP in ischemia.
Reglodi D; Vaczy A; Rubio-Beltran E; MaassenVanDenBrink A
J Headache Pain; 2018 Mar; 19(1):19. PubMed ID: 29500688
[TBL] [Abstract][Full Text] [Related]
18. Chronic ghrelin treatment reduced photophobia and anxiety-like behaviors in nitroglycerin- induced migraine: role of pituitary adenylate cyclase-activating polypeptide.
Farajdokht F; Babri S; Karimi P; Alipour MR; Bughchechi R; Mohaddes G
Eur J Neurosci; 2017 Mar; 45(6):763-772. PubMed ID: 27886414
[TBL] [Abstract][Full Text] [Related]
19. Human mast cells release the migraine-inducing factor pituitary adenylate cyclase-activating polypeptide (PACAP).
Okragly AJ; Morin SM; DeRosa D; Martin AP; Johnson KW; Johnson MP; Benschop RJ
Cephalalgia; 2018 Aug; 38(9):1564-1574. PubMed ID: 29103295
[TBL] [Abstract][Full Text] [Related]
20. Increase in trigeminal ganglion neurons that respond to both calcitonin gene-related peptide and pituitary adenylate cyclase-activating polypeptide in mouse models of chronic migraine and posttraumatic headache.
Guo Z; Czerpaniak K; Zhang J; Cao YQ
Pain; 2021 May; 162(5):1483-1499. PubMed ID: 33252452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]